Bevacizumab Study : Lung Cancer

Bevacizumab Study: Lung Cancer

Title: Multicenter, Randomised, Double blind, Parallel, Phase III Global Study to Assess the Efficacy and Safety of BP01 (Bevac-izumab) when compared to Avastin®-EU in Combination with Carboplatin and Paclitaxel during Induction phase and Bevaciz-umab alone during the Maintenance phase in patients with newly diagnosed or recurrent Stage IIIB/IV Non Squamous (ns) Non-Small Cell Lung Cancer (NSCLC).